A. Neumann-Mufweba, S. Kimani, S. F. Khan, K. Chibale, and S. Prince, “The diaryl-imidazopyridazine anti-plasmodial compound, MMV652103, exhibits anti-breast cancer activity”, EXCLI J., vol. 21, pp. 656–679, Apr. 2022.